Literature DB >> 23107979

The feasibility and advantages of billroth-I reconstruction in distal gastric cancers following resection.

M S Ganesh1, K G Reddy, D S Venkata Subbareddy.   

Abstract

BACKGROUND: Gastric carcinomas are common malignancies in southern India and distal stomach remains the commonest site in low socio economic groups. Surgery still remains an important modality of treatment to achieve local control and also relieve obstructive symptoms. In this study we investigated the feasibility of performing a gastrectomy and billroth-1 type of anastomosis in a rural cancer center setting, with parameters like adequacy of margins, ease of anastomosis and its functional results were analysed.
MATERIALS AND METHODS: Eight patients presenting to a rurally based cancer center underwent a distal gastrectomy and billroth-1 type of anastomosis for continuity restoration.
RESULTS: All the patients had adequate proximal and distal marg. The surgical time varied between-hrs. The anastomosis was constructed without any tension on bowel ends in all patients. The average time to start oral feeds varied between- None of the patients showed symptoms of bile reflux nor dumping. The average hospital stay varied between.
CONCLUSIONS: Billroth-1 anastomosis is a physiologically more natural way of restoring continuity following a gastrectomy and it is a procedure which would be technically more simpler and decrease per and post operative complications and allow speedier post operative recovery following surgery on distal gastric cancers.

Entities:  

Mesh:

Year:  2012        PMID: 23107979     DOI: 10.4103/0019-509X.102922

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  1 in total

1.  Billroth I, a Viable Alternative in Early Distal Gastric Cancers: Short-Term Results from an Indian Tertiary Care Center.

Authors:  Kalyan Pandey; Padmalaya Devi; Prafulla Kumar Das; Swodeep Mohanty; Kunal Goutam; Subrat Samantara; Bharat Bhushan Satpathy; Nilesh Patil; Mohanlal Khadia; Subhransu Sekhar Lenka
Journal:  Indian J Surg Oncol       Date:  2021-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.